4//SEC Filing
Horvath Susan 4
Accession 0001437749-19-000209
CIK 0001029125other
Filed
Jan 2, 7:00 PM ET
Accepted
Jan 3, 4:59 PM ET
Size
7.5 KB
Accession
0001437749-19-000209
Insider Transaction Report
Form 4
Horvath Susan
V.P. of Finance & CFO
Transactions
- Purchase
Convertible Promissory Note
2018-12-31+23,625→ 0 totalExercise: $3.50From: 2018-12-31Exp: 2019-06-30→ Common Stock (6,750 underlying) - Purchase
Warrant (right to buy)
2018-12-31+13,500→ 13,500 totalExercise: $4.50From: 2018-12-31Exp: 2023-12-31→ Common Stock (13,500 underlying)
Footnotes (2)
- [F1]All amounts due under the note will automatically convert into shares of common stock of the Issuer based on an initial conversion price of $3.50 per share upon maturity (subject to certain adjustments).
- [F2]The reporting person purchased the convertible promissory note and warrants, in a single transaction, for an aggregate amount of $23,625.
Documents
Issuer
Sun BioPharma, Inc.
CIK 0001029125
Entity typeother
Related Parties
1- filerCIK 0001322846
Filing Metadata
- Form type
- 4
- Filed
- Jan 2, 7:00 PM ET
- Accepted
- Jan 3, 4:59 PM ET
- Size
- 7.5 KB